Connect
MJA
MJA

Death due to intravenous use of α-pyrrolidinopentiophenone

Simon M Holliday and Huy A Tran
Med J Aust 2015; 202 (11): . || doi: 10.5694/mja14.01741
Published online: 15 June 2015

To the Editor: Sellors and colleagues report a fatality where urine drug testing (UDT) failed to detect the drug of overdose detected on the coronial blood assay.1 This highlights how clinical care may be handicapped by older testing technology.


  • 1 Albert Street Medical Centre, Taree, NSW.
  • 2 Drug and Alcohol Clinical Services, Hunter New England Local Health District, Taree, NSW.
  • 3 Pathology North (Hunter), NSW Health Pathology, Newcastle, NSW.



Competing interests:

No relevant disclosures.

  • 1. Sellors K, Jones A, Chan B. Death due to intravenous use of α-pyrrolidinopentiophenone. Med J Aust 2014; 201: 601-603. <MJA full text>
  • 2. Christo P, Manchikanti L, Ruan X, et al. Urine drug testing in chronic pain. Pain Physician 2011; 14: 123-143.
  • 3. Starr T, Rogak L, Passik S. Substance abuse in cancer pain. Curr Pain Headache Rep 2010; 14: 268-275.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.